Copy number variation in familial Parkinson disease
- PMID: 21829596
- PMCID: PMC3149037
- DOI: 10.1371/journal.pone.0020988
Copy number variation in familial Parkinson disease
Abstract
Copy number variants (CNVs) are known to cause Mendelian forms of Parkinson disease (PD), most notably in SNCA and PARK2. PARK2 has a recessive mode of inheritance; however, recent evidence demonstrates that a single CNV in PARK2 (but not a single missense mutation) may increase risk for PD. We recently performed a genome-wide association study for PD that excluded individuals known to have either a LRRK2 mutation or two PARK2 mutations. Data from the Illumina370Duo arrays were re-clustered using only white individuals with high quality intensity data, and CNV calls were made using two algorithms, PennCNV and QuantiSNP. After quality assessment, the final sample included 816 cases and 856 controls. Results varied between the two CNV calling algorithms for many regions, including the PARK2 locus (genome-wide p = 0.04 for PennCNV and p = 0.13 for QuantiSNP). However, there was consistent evidence with both algorithms for two novel genes, USP32 and DOCK5 (empirical, genome-wide p-values<0.001). PARK2 CNVs tended to be larger, and all instances that were molecularly tested were validated. In contrast, the CNVs in both novel loci were smaller and failed to replicate using real-time PCR, MLPA, and gel electrophoresis. The DOCK5 variation is more akin to a VNTR than a typical CNV and the association is likely caused by artifact due to DNA source. DNA for all the cases was derived from whole blood, while the DNA for all controls was derived from lymphoblast cell lines. The USP32 locus contains many SNPs with low minor allele frequency leading to a loss of heterozygosity that may have been spuriously interpreted by the CNV calling algorithms as support for a deletion. Thus, only the CNVs within the PARK2 locus could be molecularly validated and associated with PD susceptibility.
Conflict of interest statement
Figures





Similar articles
-
High-resolution survey in familial Parkinson disease genes reveals multiple independent copy number variation events in PARK2.Hum Mutat. 2013 Aug;34(8):1071-4. doi: 10.1002/humu.22344. Epub 2013 May 28. Hum Mutat. 2013. PMID: 23616242 Free PMC article.
-
Genome-wide analysis of rare copy number variations reveals PARK2 as a candidate gene for attention-deficit/hyperactivity disorder.Mol Psychiatry. 2014 Jan;19(1):115-21. doi: 10.1038/mp.2012.161. Epub 2012 Nov 20. Mol Psychiatry. 2014. PMID: 23164820 Free PMC article.
-
A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2.Neurology. 2010 Sep 28;75(13):1189-94. doi: 10.1212/WNL.0b013e3181f4d832. Neurology. 2010. PMID: 20876472 Free PMC article.
-
High-resolution arrays reveal burden of copy number variations on Parkinson disease genes associated with increased disease risk in random cohorts.Neurol Res. 2016 Sep;38(9):775-85. doi: 10.1080/01616412.2016.1204105. Epub 2016 Jul 11. Neurol Res. 2016. PMID: 27399248
-
Heterozygote carriers for CNVs in PARK2 are at increased risk of Parkinson's disease.Hum Mol Genet. 2015 Oct 1;24(19):5637-43. doi: 10.1093/hmg/ddv277. Epub 2015 Jul 17. Hum Mol Genet. 2015. PMID: 26188007
Cited by
-
High-resolution survey in familial Parkinson disease genes reveals multiple independent copy number variation events in PARK2.Hum Mutat. 2013 Aug;34(8):1071-4. doi: 10.1002/humu.22344. Epub 2013 May 28. Hum Mutat. 2013. PMID: 23616242 Free PMC article.
-
Potential Common Genetic Risks of Sporadic Parkinson's Disease and Amyotrophic Lateral Sclerosis in the Han Population of Mainland China.Front Neurosci. 2021 Oct 11;15:753870. doi: 10.3389/fnins.2021.753870. eCollection 2021. Front Neurosci. 2021. PMID: 34707478 Free PMC article.
-
Alpha-Synuclein and Lipids: The Elephant in the Room?Cells. 2021 Sep 17;10(9):2452. doi: 10.3390/cells10092452. Cells. 2021. PMID: 34572099 Free PMC article. Review.
-
The emerging role of guanine nucleotide exchange factors in ALS and other neurodegenerative diseases.Front Cell Neurosci. 2014 Sep 10;8:282. doi: 10.3389/fncel.2014.00282. eCollection 2014. Front Cell Neurosci. 2014. PMID: 25309324 Free PMC article. Review.
-
The Role of Genetic Testing in the Clinical Practice and Research of Early-Onset Parkinsonian Disorders in a Hungarian Cohort: Increasing Challenge in Genetic Counselling, Improving Chances in Stratification for Clinical Trials.Front Genet. 2019 Oct 31;10:1061. doi: 10.3389/fgene.2019.01061. eCollection 2019. Front Genet. 2019. PMID: 31737044 Free PMC article.
References
-
- Feuk L, Carson AR, Scherer SW. Structural variation in the human genome. Nat Rev Genet. 2006;7:85–97. - PubMed
-
- Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science. 2008;320:539–543. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous